Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 43.18 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 24.43 | Oscillator | Neutral |
| Williams %R (14) | -80.99 | Oscillator | Buy |
| MACD (12, 26, 9) | -0.34 (Hist -1.34) | Oscillator | Strong Sell |
| Average Directional Index (14) | 20.45 (+DI 15.8 / -DI 32.6) | Trend | Sell |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Aug 19, 26 | Cohade Pierre E | director | S-Sale | 3,300 @ $147.79 | $487.7K |
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
Stock news · updated daily
Johnson Controls is rated Buy with a raised target price of $168, reflecting a 12.2% upside driven by robust backlog and production gains. JCI's $21 billion backlog and strong data center demand underpin expectations for above-market revenue and operating profit growth over the next two years. Management's operational improvements and disciplined cost control are driving operating profit faster than revenue, supporting margin expansion through FY2030.
Johnson Controls is rated Buy, driven by robust demand, strong order growth, and expanding backlog, especially from data centers. JCI's margin outlook is attractive, supported by productivity gains, operating leverage, and a $500M annual cost reduction initiative targeting full implementation by FY27. Consensus expects double-digit EPS growth, with potential for upward estimate revisions as backlog conversion accelerates and capacity investments scale.
Current price $144.33
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 15, 26 |
| EMA 20 | 149.19 | MA | Strong Sell |
| SMA 20 | 151.50 | MA | Strong Sell |
| EMA 50 | 147.90 | MA | Sell |
| SMA 50 | 146.94 | MA | Sell |
| SMA 200 | 140.06 | MA | Strong Buy |
| Aug 4, 26 |
| Schlitz Lei Zhang |
| officer: VP & Pres, GP & Solutions |
| S-Sale |
| 20,917 @ $152.98 |
| $3.20M |
| Aug 4, 26 | Schlitz Lei Zhang | officer: VP & Pres, GP & Solutions | S-Sale | 2,500 @ $153.79 | $384.5K |
| Aug 2, 26 | Vandiepenbeeck Marc | officer: EVP and CFO | F-InKind | 19,760 @ $146.66 | $2.90M |
| Aug 2, 26 | Schlitz Lei Zhang | officer: VP & Pres, GP & Solutions | F-InKind | 18,625 @ $146.66 | $2.73M |
| Jul 14, 26 | Scalia Christopher M | officer: EVP and CHRO | F-InKind | 1,831 @ $145.24 | $265.9K |
| Jul 14, 26 | Scalia Christopher M | officer: EVP and CHRO | F-InKind | 2,070 @ $145.24 | $300.6K |
| Jun 9, 26 | Grabowski Todd M | officer: VP and President, Americas | S-Sale | 1,800 @ $146.20 | $263.2K |
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 29, 2026 | 1.30 | 1.42 | Beat 9.2% | $6.61B |
| May 6, 2026 | 1.12 | 1.19 | Beat 6.2% | $6.14B |
| Feb 4, 2026 | 0.84 | 0.89 | Beat 5.8% | $5.80B |
| Nov 5, 2025 | 1.20 | 1.26 | Beat 5.0% | $6.44B |
| Jul 29, 2025 | 1.01 | 1.05 | Beat 4.0% | $6.05B |
| May 7, 2025 | 0.79 | 0.82 | Beat 4.1% | $5.68B |
| 4 | Aug 4, 2026 | 2026-08-04 12:34:35 | View |
| 10-Q | Jul 29, 2026 | 2026-07-29 11:12:00 | View |
| 8-K | Jul 29, 2026 | 2026-07-29 06:57:16 | View |
| SC 13G/A | Jul 28, 2026 | 2026-07-28 16:44:43 | View |
| 4 | Jul 16, 2026 | 2026-07-16 12:25:50 | View |
| 11-K | Jun 17, 2026 | 2026-06-17 16:38:37 | View |
Proxy statement (DEF 14A) disclosures
| Mizuho |
| maintain |
| Neutral |
| Neutral |
| Oct 14, 26 | RBC Capital | maintain | Sector Perform | Sector Perform |
| Oct 12, 26 | Citigroup | maintain | Neutral | Neutral |
| Oct 8, 26 | B of A Securities | maintain | Buy | Buy |
| Sep 2, 26 | Morgan Stanley | maintain | Overweight | Overweight |
| Aug 14, 26 | Bernstein | maintain | Outperform | Outperform |
| Jul 30, 26 | RBC Capital | maintain | Sector Perform | Sector Perform |
| Jul 30, 26 | Citigroup | maintain | Neutral | Neutral |
| Jun 9, 26 | Morgan Stanley | maintain | Overweight | Overweight |
Annual filings (FY) with consensus forward estimates (hatched)
TTM vs. 5-year historical average (annual ratios)
| Metric | JCI | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 25.0x | 28.7x · sector 16.6x | Elevated |
| Forward P/E (FY26E) | 28.4x | EPS est. 5.08 | In line |
| Price / Book | 6.5x | 3.1x | Elevated |
| Price / Sales | 3.5x | 2.1x | Elevated |
| EV / EBITDA | 25.6x | 20.4x | Elevated |
| Return on equity | 26.9% | — | Top tier |
| Gross margin | 36.7% | 35.0% | In line |
| Debt / Equity | 0.70 | 0.60 | Moderate |
| Piotroski / Altman Z | 8/9 | Z 2.95 | Grey zone |
Discounted cash flow model